Panagora Asset Management’s Genocea Biosciences, Inc. GNCA Stock Holding History

Panagora Asset Management’s Portfolio GNCA Stock Details GNCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-5,778	Closed	-$23K	–	2804
2019 Q2	$23K	Sell	5,778 -8,926	-61%	-$46.6K	﹤0.01%	2257
2019 Q1	$69K	Buy	14,704 +1,210	+9%	+$5.99K	﹤0.01%	1975
2018 Q4	$31K	Sell	13,494 -2,101	-13%	-$10.5K	﹤0.01%	2111
2018 Q3	$97K	Buy	+15,595	New	+$82.3K	﹤0.01%	1870
2017 Q3	–	Sell	-236	Closed	-$10K	–	2606
2017 Q2	$10K	Buy	+236	New	+$11.4K	﹤0.01%	2461
2015 Q4	–	Sell	-296	Closed	-$16K	–	2415
2015 Q3	$16K	Sell	296 -87	-23%	-$8.63K	﹤0.01%	2172
2015 Q2	$42K	Buy	+383	New	+$35.6K	﹤0.01%	2181

Other funds holding GNCA

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Panagora Asset Management's GNCA Position: Q3 2019 in Review

Panagora Asset Management sold out of Genocea Biosciences, Inc. (GNCA) in Q3 2019, closing a stake of 5,778 shares — an estimated $23K sold.

Panagora Asset Management first reported a position in GNCA in Q2 2015 and held it in 7 quarters. The position peaked at $97K in Q3 2018. 37 funds tracked by Wall St. Rank hold GNCA as of Q3 2019.

Panagora Asset Management reported no remaining Genocea Biosciences, Inc. position as of Q3 2019 after selling out during the quarter.
Panagora Asset Management sold 5,778 Genocea Biosciences, Inc. shares in Q3 2019, an estimated $23K.
Panagora Asset Management first reported a position in Genocea Biosciences, Inc. in Q2 2015 and held it in 7 quarters.
Panagora Asset Management's Genocea Biosciences, Inc. position peaked at $97K in Q3 2018.
37 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q3 2019.

Based on Panagora Asset Management's 13F filing for Q3 2019, filed 12 Nov 2019.